Therapy Areas
24 January 2020 - - US-based biotechnology company Genentech has received positive topline results from the pivotal Part 2 of the FIREFISH study, evaluating risdiplam in infants aged 1-7 months with Type 1 spinal muscular atrophy, the company said.
24 January 2020 - - US-based molecular diagnostics company Co-Diagnostics, Inc. (NASDAQ: CODX) has completed principle design work for a PCR screening test for new coronavirus, 2019-nCoV, intended to address potential need for detection of the v...
24 January 2020 - - French biopharmaceutical company POXEL SA has appointed David E. Moller, MD, as chief scientific officer, the company said.

Moller will be responsible for leading scientific-related activities to support the adva...
24 January 2020 - - US-based Greenstone, Upjohn's US-based generics business and a wholly owned subsidiary of Pfizer Inc., and Roman, a digital healthcare clinic for men, have inked a supply agreement to offer Roman members access to the only FD...
24 January 2020 - Public health agency The US Food and Drug Administration Thursday awarded the accelerated approval for Tazverik (tazemetostat) for the treatment of adults and pediatric patients aged 16 years and older with metastatic epithelioid sa...
24 January 2020 - Gene therapy company Genprex Inc (NASDAQ:GNPX) Thursday announced the sale of 7,620,000 shares of common stock, par value USD0.001 per share, at-the-market offering price of USD1.05 per share, under purchase agreements with institut...
24 January 2020 - Biopharmaceutical company Zymeworks Inc (NYSE:ZYME) said on Thursday that it has priced its public offering of 4,924,729 common shares and, in lieu of common shares to a certain investor, pre-funded warrants to purchase up to 1,075,...